Company Quick10K Filing
International Stem Cell
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-06-19
10-K 2019-12-31 Filed 2020-06-01
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-27
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-09
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-17
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-03-26
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-06-23
10-K 2010-12-31 Filed 2011-03-24
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-23
8-K 2020-06-23 Shareholder Vote
8-K 2020-05-13
8-K 2020-04-28
8-K 2020-03-30
8-K 2019-12-17
8-K 2019-07-25
8-K 2019-06-03
8-K 2019-04-17
8-K 2019-01-21
8-K 2018-11-12
8-K 2018-09-27
8-K 2018-06-21
8-K 2018-05-31
8-K 2018-05-14
8-K 2018-03-06
8-K 2018-02-13

International Stem Cell Financials

ISCO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ForeverGreen (FVRG) 7,387 77% 43.6 -50% 3,316 11,504 11,815 9,132 -1,674 178 7,750
Castle AM (CTAM) 7,373 0% 45.0 -8% 346,985 382,366 433,570 0 -28,503 5,827 261,951
Sonic Foundry (SOFO) 7,343 73% -4.2 -24% 15,180 21,433 34,781 25,501 -3,612 -2,241 9,445
RXI Pharmaceuticals (RXII) 7,253 0% -0.5 -194% 3,809 2,059 138 0 -7,398 -7,315 3,963
Ethema Health (GRST) 7,193 0% -1.2 -32% 23,469 33,429 599 0 -7,507 -6,127 7,192
Vivos (RDGL) 7,143 0% -7.6 -561% 197 1,390 8 0 -1,106 -971 7,400
Mikros Systems (MKRS) 7,118 61% -32.0 -4% 3,336 1,082 4,891 3,003 -132 -164 5,234
Pressure Biosciences (PBIO) 7,038 41% -1.9 -331% 2,411 12,035 1,530 630 -7,979 -3,691 6,902
MGT Capital Investments (MGTI) 7,028 -31% -0.6 -144% 5,265 1,955 190 -58 -7,582 -7,576 4,915
International Stem Cell (ISCO) 7,018 62% -5.0 -19% 8,260 4,636 6,635 4,138 -1,551 -1,322 6,555
Star Gold (SRGZ) 6,966 -29.3 -31% 751 35 0 0 -235 -235 6,865
Westmoreland Coal (WLB) 6,952 22% -73.7 -15% 1,467,857 2,190,755 1,264,675 282,069 -219,134 -13,208 973,082
Vaso (VASO) 6,906 54% -5.8 -7% 45,928 43,364 51,794 28,138 -3,037 -964 5,563
Scientific Industries (SCND) 6,822 43% 6.9 5% 8,863 2,553 10,165 4,402 447 801 5,562
Vitality Biopharma (VBIO) 6,792 0% -0.2 -324% 4,197 1,644 95 0 -13,584 -13,577 2,833
Avant Diagnostics (AVDX) 6,739 -3.1 -52% 4,907 3,030 0 0 -2,557 -2,262 6,910
Video Display (VIDE) 6,701 25% -52.2 -3% 9,802 5,465 13,711 3,469 -313 -119 6,215
Boston Therapeutics (BTHE) 6,668 0% -4.7 -207% 743 6,362 13 0 -1,537 -1,423 6,659
China Xuefeng Environmental (CXEE) 6,652 59% -1.6 6% 87,699 19,594 14,414 8,439 5,217 9,810 -16,127
Textmunication Holdings (TXHD) 6,569 61% -2.2 -559% 541 566 758 460 -3,023 -3,023 6,668

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3,5822,5841,3376,0134,2852,3806541,9126541,7922,2439917484711,1116115545995321,5427687331106762975103044474771,1611,075615595463
Accounts Receivable3422461402572104112733844543983065014064644534363616155394615185955746156056844659391,6141,5456519579761,080
Inventory1,3291,4971,2681,2281,2721,1221,1991,2061,3701,3601,3691,3571,4701,5331,5171,6681,7591,8741,3481,4341,3681,2841,3901,4231,3901,3521,3071,3851,6821,4741,5011,4601,3171,409
PP&E1,4961,5171,4201,3562,3892,4872,4742,4742,4542,4772,3642,3772,5822,5862,6102,6252,6312,6372,6232,6842,7672,7972,8242,8322,8842,9132,9072,9623,0543,0633,1213,3173,3993,434
Assets8,1127,3255,73710,5868,9097,1165,3706,8156,0986,9277,7396,6526,6156,3647,1796,6936,8857,2307,1388,3887,8617,5407,0457,8557,6147,9536,8647,4688,4168,7257,7968,6638,5418,260
Accounts Payable7435225325187987156701,7655805261,0926027437968417253918488301,6121,817799458806731722
Long-Term Debt
Liabilities3,3032,1892,1146,9177,2706,9057,1286,5357,51711,33011,96210,9896,9807,2106,8586,7726,0806,3965,54421,2408,8437,1153,6017,2176,0218,1394,8005,8296,7735,9395,2595,4775,4324,636
Stockholders' Equity4,8095,1363,6233,6691,639211-1,758280-1,419-4,403-4,223-4,337-365-846321-798058341,594-12,852-9824253,4446381,593-1862,0641,6391,6432,7862,5373,186-1,191-676
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,1148421,0611,0772,1331,1871,2472,5321,5551,6701,7351,6491,5881,9631,8171,6221,8152,1361,9781,6161,9161,9431,6902,0051,7621,8471,8422,6333,0383,1952,2182,3212,096
Cost of Revenue3623614673246373203156493434475334394095185554185165655573775066064555534714746248251,0951,315841857799
Gross Profit7524815947531,4968679321,8831,2121,2231,2021,2101,1791,4451,2621,2041,2991,5711,4211,2391,4101,3371,2351,4521,2911,3731,2181,8081,9431,8801,3771,4641,297
R&D1,1291,1301,1729371,8029008971,6189749329339581,4371,3921,6251,11856750851457985267974664573967060481145261665326879
SG&A2,4822,4732,3302,5354,8382,0472,6244,5542,3463,1422,2062,3172,2972,0871,2832,0521,6691,6851,9461,8271,8071,9201,6621,8531,5541,6732,5382,1821,8571,9272,2132,1372,031
Tax0-00000000000000000000000000
Net Income-2,389-2,564-2,624-2,677-2,477-2,081-2,598-1,712-2,200-3,799-2,767-1,435-4,410-2,034-4,599-1,287723-539-1,532-14,57310,9194142,161-3,084568-2,164-1,389-830-393121-906-6483
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2,564-1,431-2,025-3,460-1,659-1,570-1,847-1,046-1,340-1,405-2,031-1,326-1,097-1,961-764-2,124-558-674-1,969-863-426-939-571-759-319-493-48-558-288-59524
Cash Investing-291-132-216-449-181-1569,924-205-141-382-156-402-188-241-167-195-168-208-221-309-230-183-163-320-168-213-201-133-119-172-105
Cash Financing1,8573166,9176,857-6503,273-72,6192,2389351,4851,0082,8424312,2627718153,2003986214991,3007007005003921,375-53747-51